Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.07

€1.07

-1.670%
-0.017
-1.670%
€3.00
 
01.10.24 / Tradegate WKN: A1412H / Name: Aclaris / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Aclaris Therapeutics Inc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Aclaris

sharewise wants to provide you with the best news and tools for Aclaris, so we directly link to the best financial data sources.

News

3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices: https://www.marketbeat.com/logos/articles/med_20240710114454_chart-crsp-7102024ver001.png
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices

Trading volume spikes in beaten-down stocks often signal a bottom for prices investors can bank on. The problem is that beaten-down stocks are usually in that position for a good reason, so it